Speaker Profile
Biography
Reem Mahrat, Founder of Eaze Bio, is a biotech visionary advancing womens health through innovative diagnostics and therapies. She also leads EGE, transforming healthcare with precision medicine and epigenetic gene editing. Previously, she successfully scaled and exited RamanID and Calico Bio Labs. As Entrepreneur in Residence at Daybreak Labs, Reem mentors emerging innovators, fostering breakthroughs in diagnostics and therapeutics. A passionate advocate for equity, her upcoming book empowers readers to take control of their health.
Talk
Revolutionizing Womens Health: Precision Medicine Meets Empowerment
Discover how Eaze Bio is pioneering next-generation diagnostics to transform womens health. Founder Reem Mahrat highlights innovative approaches addressing unmet needs, from early detection to precision therapies, empowering women with cutting-edge solutions that redefine the future of personalized healthcare and advance equity in wellness worldwide.
Clinical Dx Showcase:
Eaze Bio
Eaze Bio revolutionizes women’s health with next-generation diagnostics and precision medicine. Focused on early detection and personalized solutions, the company empowers women globally by addressing critical healthcare gaps with cutting-edge innovation and compassion.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Data Applications in Clinical Diagnostics Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative